Mahindra University, Apollo Healthcare academy sign MoU

IMT News Desk
IMT News Desk
· 2 min read
Dr Yajulu Medury (2nd from Left), Vice Chancellor, Mahindra University; Mr. Sivaramakrishnan Venkateswaran (3rd from Left), CEO, Apollo Knowledge; flanked by (L-R) Dr. Rajinder Singh Chauhan, Professor & Dean, Centre for Life Sciences, Mahindra University; Dr. Jagadeswaran, Dean & Head, Allied & Healthcare Professions, Apollo Institute of Hospital Management & Allied Sciences and Mr. Asheesh Sharma, Chief Business Officer, Apollo Knowledge; exchanging an MoU on behalf of Mahindra University, Hyderabad, and Apollo Healthcare Academy to collaboratively offer Bachelor’s programs in Allied Health Sciences, today at Mahindra University, Hyderabad.

To launch allied health sciences bachelor’s prog

Mahindra University, Hyderabad and Apollo Healthcare Academy announced the signing of a Memorandum of Understanding (MoU) to collaboratively offer Bachelor’s programmes in Allied Health Sciences. This strategic partnership aims to address the growing shortage of allied health professionals in India and worldwide, equipping students with both academic excellence and immersive clinical training.

The programmes will focus on high-demand specializations such as Anesthesia & Operation Theatre Technology, Medical Laboratory Technology, Cardiovascular Technology, among others. By combining Mahindra University’s modern academic infrastructure with Apollo Healthcare Academy’s clinical expertise, the collaboration will produce practice-ready graduates aligned with healthcare industry needs.

The curriculum will follow the guidelines set by the National Commission for Allied & Healthcare Professionals (NCAHP), ensuring national regulatory compliance and global recognition. Students will also benefit from clinical rotations at Apollo Hospitals and affiliated healthcare facilities, including a final-year internship.

Dr Yajulu Medury, Vice Chancellor, Mahindra University, said, “This collaboration reflects our shared vision of producing highly skilled healthcare professionals. By integrating Mahindra University’s interdisciplinary academic strengths with Apollo’s proven expertise in healthcare, we aim to nurture graduates who will make an immediate and lasting impact on society.”

Dr Rajinder Singh Chauhan, Professor & Dean, Centre for Life Sciences, Mahindra University, added, “These programmes combine academic rigour with practical immersion. Our students will not only learn but also practice in real healthcare settings, making them job-ready and future-ready.”

Sivaramakrishnan Venkateswaran, CEO, Apollo Knowledge, said, “Apollo Healthcare Academy is committed to bridging the gap between classroom learning and hospital practice. This partnership will empower students with the confidence, exposure, and skill set required to thrive not only in India but also in global opportunities. This is part of our global workforce development initiatives to build and empower the next generation of healthcare professionals equipped to contribute meaningfully to health systems worldwide.”

Dr Jagadeswaran, Dean & Head – Allied & Healthcare Professions, Apollo Institute of Hospital Management & Allied Sciences, commented: “We are proud to bring Apollo’s immersive training model into Mahindra University. Together, we will prepare allied health graduates who are globally relevant and locally impactful.”

Read Next

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk
Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk